Sabaa International Company for Pharmaceutical and Chemical Industry (EGX:SIPC)

Market Cap	372.50M
Revenue (ttm)	22.78M
Net Income (ttm)	-18.04M
Shares Out	250.00M
EPS (ttm)	-0.07
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,874,242
Average Volume	4,347,957
Open	1.550
Previous Close	1.550
Day's Range	1.530 - 1.570
52-Week Range	0.620 - 1.850
Beta	0.70
RSI	64.33
Earnings Date	May 29, 2025

About EGX:SIPC

Sabaa International Company for Pharmaceutical and Chemical Industry engages in the manufacture and sale of generic medicines in Egypt. It provides hard gelatin capsules, such as Acitretin; film coated tablets, including Saboctic, Topiramate, and Tolterodine; and tablets, such as Claudol and Flamogen E.C.T. The company also offers OTCs, food supplements, and veterinary products, as well as medicine trials services. The company was founded in 2000 and is based in Cairo, Egypt.

• Industry: Pharmaceutical Preparations
• Founded: 2000
• Employees: 165
• Stock Exchange: Egyptian Stock Exchange
• Ticker Symbol: SIPC